Not to be a jerk, but it's about what _you_ value. If you value money (or lifestyle, or whatever drew you to advertising) over whatever you were doing previously, you've had your way. If you don't, you have the choice to go back.
Don't feel bad about not working in the right industry; just remember that there are thousands of ways to help progress the state of the art, raise money or awareness for those progressing the state of the art, or even just helping people and their families dealing with cancers.
I don't work in a philanthropic job. I would like to, but value the financial stability of something further removed from pure altruism.
In practice, we spend $31B or so on the NIH [1], but we have $170B in fiscal year 2010 [2] for Iraq and Afghanistan, plus all the tail costs involved.
[1] http://www.nih.gov/about/director/budgetrequest/NIH_BIB_0209...
And, by the way, you have not refuted grandparent at all. Much on the contrary, you have only ratified that you have chosen money and lifestyle over working on something you believe in. I don't think gp was judging you for that, only saying that was indeed your choice.
The two aren't incompatible. He chose the money. If society truly valued medical research, he wouldn't have had to make that choice -- the money would be in medical research.
It seems patently obvious to me that the structure of our pharmaceutical system encourages maintenance doses over cures, and I'm not sure what about that would provoke at least four people to take action not to see it.
PS: People talk about drug companies funding research, but mostly they just do refinements and late stage clinical trials. They have minimal impact on the type of research that actually discovers how things work or the basic ideas for how to fix things and if a cure for a major ailment was possible they would jump on even a modest cash cow.
I remain convinced that funds could be allocated somewhat better. In this as in so very many other things.
I'm generalizing, but It seems as if institutions who have made a living researching treatments to major diseases don't seem that interested in cures. That could threaten their existence. So they put their money in providing hospital services instead of research. They can't get government money for research grants if their idea for research seems too unorthodox.
In the end, it's about protecting jobs and finding a way for you to live longer with the disease.
As is always the refrain, the system is broken - if what you want is cures instead of a large and lucrative pharmaceutical industry.
This bothers me greatly.
I don't want to threadjack, but are any HN'ers aware of discussion elsewhere about what concerned members of society who do value biomed progress more strongly than most, but who don't have Milken-level money might be able to do to promote faster progress?
I'd be very interested in exploring how YC-like entrepreneurial energy could be unleashed on improving human health, and would be willing to chip in.
http://www.fightaging.org/archives/2010/12/peter-thiel-encou...
In short big philanthropy needs a component that looks a lot like the venture capital industry, and doesn't currently have it. Lots of smaller, big risk, potentially game changing bets rather than stultifying into safe big-budget, incremental institutional irrelevance.
In this case, for example, this research was rescued from years further of oblivion by a funding source that was willing to take a risk.
Much thinking has taken place on this. You might look at some of Aubrey de Grey's early publications on the triangular log jam for example:
http://www.fightaging.org/archives/2004/06/the-curious-case-...
Product cycle is much slower in the biomed industry and much more expensive. Potential financial gains are high, but risk is also very high. Even getting started in this industry means a hefty investment is necessary.
In short, not really suitable for a YC-like incubator. At least not at this point.
I did join a stem cell related company from their beginnings. It was cool to see it grow thinking I was doing good, until I realized at least in my case it was more about making the owners money rather than finding cures for these kind of diseases.
Quitting the day job and switching to biomed maybe could help, but I believe instead there's a need to start something more radical rather than being +1 cog.
Usually you have to pay brain surgeons and CEOs orders of magnitude more money to take those jobs, when normally they might prefer to live off the glory of cleaning up after slobs.
My father died of type 2 non hodkins lymphoma in 1997 when I was 17; he was sick for 4 years from two rounds of lymphoma, plus a marrow transplant. Every time I read about advances like this I feel bad about wasting my life building better advertising instead of doing biomed. I just wish biomed paid better wages -- I much more than doubled my income by leaving a wetlab and doing advertising instead. It's a lesson in what our society really values. And now I feel like Steve Yegge.